Note: Ingredients listed on restricted chemical lists
EC/CAS
56-55-3
Name of the chemical
Benzo[a]anthracen (790/2009)
Concentration
>98
General Information
Revision date
2006-06-19
Product name
Benz[alanthracene
Product Synonyms
B(A)A; BA; BAA; 1,2-BENZ(A)ANTHRACENE; 1,2-BENZANTHRACENE; BENZ(A)ANTHRACENE; BENZANTHRACENE; BENZ[AJANTHRACENE; 1,2-BENZANTHRAZEN; 1,2- BENZANTHRENE; BENZANTHRENE; 1|,2-BENZOANTHRACENE; BENZO(A)ANTHRACENE;
CAS No.
56-55-3
1.2.1 Relevant identified uses
research chemistry
Icons in SDS
Company Information
company name
group inc
GHS Information
Signal word
Danger!
Section 2
SECTION 2: Hazards identification
Flammability Toxicity Body Contact Reactivity Chronic 1 2 3 4 Min Low Moderate High Extreme ANSI Signal Word a Danger! Poison weve Emergency Overview * % % % ¥ Colorless plates. May cause irritation. Poison. Other Acute Effects: may be fatal if inhaled, swallowed, or absorbed through skin. Chronic Effects: may cause heritable genetic damage; may alter genetic material. Carcinogen. Will burn.
Potential health effects
Target Organs: No data found.
Principle Routes of Exposure
accidental skin and eye contact, inhalation of generated dusts Acute Effects Inhalation: The dust is harmful and discomforting to the upper respiratory tract. Persons with impaired respiratory function, airway diseases, or conditions such as emphysema or chronic bronchitis may incur further disability if excessive concentrations of particulate are inhaled. Eye: The dust may be discomforting to the eyes and is capable of causing a mild, temporary redness of the conjunctiva (similar to wind-burn), temporary impairment of vision and/ or other transient eye damage/ ulceration. Skin: The material may be mildly discomforting to the skin. Open cuts and abraded or irritated skin should not be exposed to this material. Toxic effects may result from skin absorption. Copyright © 2006 by Genium Group, Inc. Any commercial use or reproduction without the publisher’s permission is prohibited. Judgments as to the suitability of information herein for the purchaser’ s purposes are necessarily the purchaser’s responsibility. Although reasonable care has been taken in the preparation of such information, Genium Group, Inc. extends no warranties, makes no representations, and assumes no responsibility as to the accuracy or suitability of such information for application to the purchaser’s intended purpose or for consequences of its use. Ingestion: The solid/dust is discomforting to the gastrointestinal tract and harmful if swallowed. Considered an unlikely route of entry in commercial/industrial environments. Carcinogenicity: NTP - Class 2B, Reasonably anticipated to be a carcinogen, sufficient evidence of carcinogenicity from studies in experimental animals; IARC - Group 2A, Probably carcinogenic to humans; OSHA - Not listed; NIOSH - Not listed; ACGIH - Class A2, Suspected human carcinogen; EPA - Class B2, Probable human carcinogen based on animal studies; MAK - Class A2, Unmistakably carcinogenic in animal experimentation only.
Potential chronic health
Cited in many publications and by a number of regulatory authorities as a suspected human carcinogen. Subcutaneous injection produces sarcomas (soft tissue growths) in rats and mice. When administered by gavage benz[a]anthracene induced papillomas to the forestomach in mice and hamsters and mammary tumors in female rats.
